The Digital Pathology Market is expected to witness market growth at a rate of f 12.5% the forecast period of 2022 to 2

Data Bridge Market Research analyses that the digital pathology market which was USD 971.49 million in 2021, is expected to reach USD 2,492.64 million by 2029, at a CAGR of 12.5% during the forecast period 2022 to 2029.

The most excellent Global  Digital Pathology Market research report proves to be an innovative and new solution for the businesses in today’s varying market place. This market report supports businesses to thrive in the market by providing them with an array of insights about the market and the Automotive industry. It includes key information about the industry, market segmentation, important facts and figures, expert opinions, and the latest developments across the globe. The research study that has taken place in this global market report covers the local, regional as well as global market. The superior Global  Digital Pathology Market report comprises of information and data in the form of charts, tables and graphs which is easy to understand for the users.
 
The market studies, market insights and market analysis encompassed in Global  Digital Pathology Market research report keeps marketplace clearly into the focus with which ladder of the success can be climbed quickly and easily. Market segmentation analysis conducted in this persuasive market research report with respect to product type, applications, and geography is very encouraging in taking any verdict about the products. Global  Digital Pathology Market report takes into consideration the market type, size of the organization, availability on-premises, end-users’ organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East Africa to analyse the data. 
 
Data Bridge Market Research analyses that the digital pathology market which was USD 971.49 million in 2021, is expected to reach USD 2,492.64 million by 2029, at a CAGR of 12.5% during the forecast period 2022 to 2029.
 
Download Sample PDF Copy of this Report to understand structure of the complete report (Including Full TOC, Table Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-digital-pathology-market
 
Market Overview
 
Digital pathology is the practise of pathology that employs digital imaging. Digital pathology is the use of computer workstations to view digital whole slide images (WSIs) obtained from high resolution scanning of glass microscope slides applications include teaching, research and primary diagnostic reporting.
 
Some of the major players operating in the digital pathology market are:
 
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Hamamatsu Photonics (Japan)
  • 3DHISTECH Ltd. (Hungary)
  • AstraZeneca (U.K.)
  • General Electric (U.S.)
  • Healthcare Trading Co. LLC (UAE)
  • Koninklijke Philips N.V (Netherlands)
  • Inspirata, Inc. (U.S.)
  • Olympus Corporation (Japan)
  • Sectra AB (U.S.), PerkinElmer Inc. (U.S.)
  • Apollo Enterprise Imaging Corp (U.S.)
  • Mikroscan Technologies, Inc. (U.S.)
  • VMscope GmbH (Germany)
  • Huron Technologies International Inc. (Canada)
  • Objective Pathology Services Limited (Canada)
  • OptraScan (U.S.)
  • Pathcore (Canada)
  • Agfa-Gevaert Group (Belgium)
  • Proscia Inc. (U.S.)
 
Global Digital Pathology Market Dynamics
 
Drivers
 
  • Rapid technological advancements are fostering the market growth
Rapid technological advancements in digital pathology systems are also expected to drive market expansion. Digital imaging, computerization, robotic light microscopy, and multiple fibre optic communications are all contributing to the expansion. Whole slide imaging is one such technique that has several advantages over conventional light microscopes and is expected to boost the market.
 
  • Rising use of AI in healthcare
The use of AI in healthcare is increasing, with a growing emphasis on improving patient care quality by incorporating AI into various aspects of healthcare services, such as pathological diagnosis. As a result, artificial intelligence (AI) provides smooth primary care flow and automation, allowing doctors to focus on more essential and horrific patients. Furthermore, AI solutions in the healthcare industry are becoming more humanized.
 
Opportunities
 
  • Growing preference for computer-aided diagnosis
The growing preference for computer-aided diagnosis, which integrates image processing, physics, mathematics, and computing algorithms, enables efficient disease detection, and aids in the evaluation of anatomic structures of interest, as well as the quantification of disease progression and risk assessment, will drive market growth. Companies such as Olympus are providing a variety of tools for remote slide sharing and image processing, which is expected to drive market growth in the coming years. Leica Biosystems received FDA approval for the Aperio AT2 DX Scanner and Aperio WebViewer for remote diagnosis during the pandemic in April 2020. During this emergency, Phillips also received FDA approval for its IntelliSite Pathology Solution for remote diagnosis.
 
Restraints/Challenges
 
  • High cost of digital pathology
High cost of digital pathology and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. Augmenting keeps the cost of digital pathology low by functioning as a modular hardware platform with integrated digital pathology software applications.
 
This digital pathology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the digital pathology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
 
 
Highlights of TOC
 
Chapter 1: Market overview
 
 
Chapter 3: Regional analysis of the Global Smart Diabetes Management industry
 
Chapter 4: Global Smart Diabetes Management segmentation based on types and applications
 
Chapter 5: Revenue analysis based on types and applications
 
Chapter 6: Market share
 
Chapter 7: Competitive Landscape
 
Chapter 8: Drivers, Restraints, Challenges, and Opportunities
 
Chapter 9: Gross Margin and Price Analysis
 
 
Browse Trending Reports:
 
 
 
 
 
 
 
About Data Bridge Market Research:
 
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
 
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
 
Contact Us: -
 
Data Bridge Market Research     
 
US: +1 888 387 2818
 
United Kingdom: +44 208 089 1725
 
Hong Kong: +852 8192 7475
 
Email: – sopan.gedam@databridgemarketresearch.com         

prachi kolhe

643 Blog posts

Comments